Published in Psychol Assess on September 17, 2012
Brief report: cognitive performance in autism and Asperger's syndrome: what are the differences? J Autism Dev Disord (2013) 0.76
Endothelial dysfunction in small arteries of essential hypertensive patients: role of cyclooxygenase-2 in oxidative stress generation. Hypertension (2013) 2.82
The assessment of endothelial function: from research into clinical practice. Circulation (2012) 2.68
Relationship between wave reflection and renal damage in hypertensive patients: a retrospective analysis. J Hypertens (2013) 1.98
Comparison of single-pill strategies first line in hypertension: perindopril/amlodipine versus valsartan/amlodipine. J Hypertens (2015) 1.97
Endothelial dysfunction as a target for prevention of cardiovascular disease. Diabetes Care (2009) 1.91
Vascular effects and safety of dalcetrapib in patients with or at risk of coronary heart disease: the dal-VESSEL randomized clinical trial. Eur Heart J (2012) 1.91
Lack of pharmacokinetic bioequivalence between generic and branded amoxicillin formulations. A post-marketing clinical study on healthy volunteers. Br J Clin Pharmacol (2009) 1.81
Is oxidative stress a therapeutic target in cardiovascular disease? Eur Heart J (2010) 1.67
Assessment of flow-mediated dilation reproducibility: a nationwide multicenter study. J Hypertens (2012) 1.62
Endothelium-dependent contractions in hypertension. Br J Pharmacol (2005) 1.59
Effect of oral contraceptives on endothelial function in the peripheral microcirculation of healthy women. J Hypertens (2003) 1.49
Physical activity, plasma antioxidant capacity, and endothelium-dependent vasodilation in young and older men. Am J Hypertens (2005) 1.49
Effect of sulfaphenazole on tissue plasminogen activator release in normotensive subjects and hypertensive patients. Circulation (2009) 1.49
Angiotensin receptor blockers: therapeutic targets and cardiovascular protection. Blood Press (2005) 1.49
Different effect of antihypertensive drugs on conduit artery endothelial function. Hypertension (2003) 1.48
Soluble CD40 ligand is predictive of combined cardiovascular morbidity and mortality in patients on haemodialysis at a relatively short-term follow-up. Nephrol Dial Transplant (2011) 1.40
A polymorphism in the cyclooxygenase 2 gene as an inherited protective factor against myocardial infarction and stroke. JAMA (2004) 1.40
Tissue-type plasminogen activator release in healthy subjects and hypertensive patients: relationship with beta-adrenergic receptors and the nitric oxide pathway. Hypertension (2008) 1.39
Supplementation with vitamins C and E improves arterial stiffness and endothelial function in essential hypertensive patients. Am J Hypertens (2007) 1.36
The T-786C and Glu298Asp polymorphisms of the endothelial nitric oxide gene affect the forearm blood flow responses of Caucasian hypertensive patients. J Am Coll Cardiol (2003) 1.33
Endothelium-dependent contractions and endothelial dysfunction in human hypertension. Br J Pharmacol (2009) 1.27
The eye and the heart. Eur Heart J (2013) 1.18
Endothelial dysfunction and oxidative stress in chronic renal failure. J Nephrol (2004) 1.17
Vascular generation of tumor necrosis factor-α reduces nitric oxide availability in small arteries from visceral fat of obese patients. J Am Coll Cardiol (2011) 1.16
Hydrogen sulphide: novel opportunity for drug discovery. Med Res Rev (2010) 1.11
Characterization of a mutagenic DNA adduct formed from 1,2-dibromoethane by O6-alkylguanine-DNA alkyltransferase. J Biol Chem (2003) 1.10
Sympathetic regulation of vascular function in health and disease. Front Physiol (2012) 1.07
Hypertension and endothelial dysfunction: therapeutic approach. Curr Vasc Pharmacol (2012) 1.06
Paradoxical enhancement of the toxicity of 1,2-dibromoethane by O6-alkylguanine-DNA alkyltransferase. J Biol Chem (2002) 1.03
Oxidative stress, chronic inflammation, and telomere length in patients with periodontitis. Free Radic Biol Med (2010) 1.02
Cyclooxygenase-1 is involved in endothelial dysfunction of mesenteric small arteries from angiotensin II-infused mice. Hypertension (2006) 1.02
Interactions between sympathetic nervous system and endogenous endothelin in patients with essential hypertension. Hypertension (2010) 0.97
Oxidative Stress and Vascular Damage in Hypertension: Role of Angiotensin II. Int J Hypertens (2011) 0.96
Ramipril dose-dependently increases nitric oxide availability in the radial artery of essential hypertension patients. J Hypertens (2007) 0.96
Atorvastatin prevents endothelial dysfunction in mesenteric arteries from spontaneously hypertensive rats: role of cyclooxygenase 2-derived contracting prostanoids. Hypertension (2009) 0.96
Recombinant human thyrotropin reduces endothelium-dependent vasodilation in patients monitored for differentiated thyroid carcinoma. J Clin Endocrinol Metab (2006) 0.95
Non-invasive diagnostic tools for investigating endothelial dysfunction. Curr Pharm Des (2008) 0.94
Reaction of aflatoxin B(1) oxidation products with lysine. Chem Res Toxicol (2002) 0.94
Anthropometric and dietary determinants of blood pressure in over 7000 Mediterranean women: the European Prospective Investigation into Cancer and Nutrition-Florence cohort. J Hypertens (2008) 0.93
Intima media thickness, pulse wave velocity, and flow mediated dilation. Cardiovasc Ultrasound (2014) 0.92
Poor sleep quality and resistant hypertension. Sleep Med (2013) 0.91
Renal vasodilating capacity and endothelial function are impaired in patients with obstructive sleep apnea syndrome and no traditional cardiovascular risk factors. J Hypertens (2013) 0.90
Rationale and design of dal-VESSEL: a study to assess the safety and efficacy of dalcetrapib on endothelial function using brachial artery flow-mediated vasodilatation. Curr Med Res Opin (2010) 0.90
Effects of antihypertensive treatment on endothelial function. Curr Hypertens Rep (2011) 0.89
Metabolic syndrome and vascular alterations in normotensive subjects at risk of diabetes mellitus. Hypertension (2007) 0.88
Adipocytokine levels mark endothelial function in normotensive individuals. Cardiovasc Diabetol (2012) 0.88
Vascular reactivity in congenital hypogonadal men before and after testosterone replacement therapy. J Clin Endocrinol Metab (2006) 0.88
Cyclooxygenase-2 inhibition improves vascular endothelial dysfunction in a rat model of endotoxic shock: role of inducible nitric-oxide synthase and oxidative stress. J Pharmacol Exp Ther (2004) 0.88
Local carotid stiffness and intima-media thickness assessment by a novel ultrasound-based system in essential hypertension. Atherosclerosis (2012) 0.87
Investigation of skin vasoreactivity and blood flow oscillations in hypertensive patients: effect of short-term antihypertensive treatment. J Hypertens (2011) 0.87
Human endothelial dysfunction: EDCFs. Pflugers Arch (2010) 0.86
Inflammation and not cardiovascular risk factors is associated with short leukocyte telomere length in 13- to 16-year-old adolescents. Arterioscler Thromb Vasc Biol (2012) 0.86
Reversibility of the endothelial dysfunction after CPAP therapy in OSAS patients. Int J Cardiol (2011) 0.86
Cholecalciferol administration blunts the systemic renin-angiotensin system in essential hypertensives with hypovitaminosis D. J Renin Angiotensin Aldosterone Syst (2013) 0.86
Endothelial dysfunction in essential hypertension: clinical implications. J Hypertens (2002) 0.86
The ageing endothelium, cardiovascular risk and disease in man. Exp Physiol (2008) 0.85
Circulating matrix metalloproteinase-3 and metalloproteinase-9 and tissue Doppler measures of diastolic dysfunction to risk stratify patients with systolic heart failure. Am J Cardiol (2010) 0.85
Hyperhomocyst(e)inemia: is this a novel risk factor in hypertension? J Nephrol (2002) 0.84
A bulky platinum triamine complex that reacts faster with guanosine 5'-monophosphate than with N-acetylmethionine. J Inorg Biochem (2009) 0.84
O6-alkylguanine-DNA alkyltransferase has opposing effects in modulating the genotoxicity of dibromomethane and bromomethyl acetate. Chem Res Toxicol (2004) 0.84
Predictive role of renal resistive index for clinical outcome after revascularization in hypertensive patients with atherosclerotic renal artery stenosis: a monocentric observational study. Cardiovasc Ultrasound (2014) 0.84
Central blood pressure, arterial stiffness, and wave reflection: new targets of treatment in essential hypertension. Curr Hypertens Rep (2009) 0.84
Osteopontin is associated with increased arterial stiffness in rheumatoid arthritis. Mol Med (2009) 0.83
Functional and structural alterations of large arteries: methodological issues. Curr Pharm Des (2013) 0.83
Angiotensin-converting enzyme inhibitors: first-line agents in cardiovascular protection? Eur Heart J (2012) 0.83
Phosphodiesterase 5 inhibition in essential hypertension. Curr Hypertens Rep (2008) 0.83
Effect of acute administration of vitamin C on muscle sympathetic activity, cardiac sympathovagal balance, and baroreflex sensitivity in hypertensive patients. Am J Clin Nutr (2012) 0.82
Coronary flow reserve in idiopathic dilated cardiomyopathy: relation with left ventricular wall stress, natriuretic peptides, and endothelial dysfunction. J Am Soc Echocardiogr (2009) 0.82
Chronic treatment with long-acting nifedipine reduces vasoconstriction to endothelin-1 in essential hypertension. Hypertension (2006) 0.82
Inducible nitric oxide synthase is involved in endothelial dysfunction of mesenteric small arteries from hypothyroid rats. Endocrinology (2008) 0.82
Neuroendocrine markers and psychological features in patients with irritable bowel syndrome. Int J Colorectal Dis (2013) 0.82
Effect of alterations of key active site residues in O6-alkylguanine-DNA Alkyltransferase on its ability to modulate the genotoxicity of 1,2-dibromoethane. Chem Res Toxicol (2007) 0.82
Effect of aliskiren treatment on endothelium-dependent vasodilation and aortic stiffness in essential hypertensive patients. Eur Heart J (2012) 0.82
Peripheral wave reflection and endothelial function in untreated essential hypertensive patients with and without the metabolic syndrome. J Hypertens (2008) 0.81
Enhanced proatherogenic inflammation after recombinant human TSH administration in patients monitored for thyroid cancer remnant. Clin Endocrinol (Oxf) (2008) 0.80
Vascular dysfunction in a mouse model of Rett syndrome and effects of curcumin treatment. PLoS One (2013) 0.80
Endothelium-dependent vasodilation and carotid artery wall remodeling in athletes and sedentary subjects. Atherosclerosis (2005) 0.80
The sulfaphenazole-sensitive pathway acts as a compensatory mechanism for impaired nitric oxide availability in patients with primary hyperparathyroidism. Effect of surgical treatment. J Clin Endocrinol Metab (2009) 0.80
Resistance artery mechanics and composition in angiotensin II-infused mice: effects of cyclooxygenase-1 inhibition. Eur Heart J (2011) 0.79
Psychological predictors of the antihypertensive effects of music-guided slow breathing. J Hypertens (2010) 0.79
Association between short leukocyte telomere length, endotoxemia, and severe periodontitis in people with diabetes: a cross-sectional survey. Diabetes Care (2014) 0.79
Fixed dose combination of perindopril and indapamide improves peripheral vascular function in essential hypertensive patients. Am J Hypertens (2009) 0.79
Skin vasodilator effect of exogenous urotensin-II in hypertensives not exposed to antihypertensive medication. Blood Press (2008) 0.79
Effects of amine ligand bulk and hydrogen bonding on the rate of reaction of platinum(II) diamine complexes with key nucleotide and amino acid residues. Inorganica Chim Acta (2012) 0.78
Soy protein diet improves endothelial dysfunction in renal transplant patients. Nephrol Dial Transplant (2006) 0.78
Nitric oxide modulates tissue plasminogen activator release in normotensive subjects and hypertensive patients. Hypertension (2007) 0.78
Evaluation of microvascular structure in humans: a 'state-of-the-art' document of the Working Group on Macrovascular and Microvascular Alterations of the Italian Society of Arterial Hypertension. J Hypertens (2014) 0.78
Plasma matrix metalloproteinase-9 better predicts outcome than N-terminal protype-B natriuretic peptide in patients with systolic heart failure and a high prevalence of coronary artery disease. Biomed Pharmacother (2009) 0.78
Evaluation of endothelial function by flow mediated dilation: methodological issues and clinical importance. High Blood Press Cardiovasc Prev (2014) 0.78
Rosuvastatin prevents angiotensin II-induced vascular changes by inhibition of NAD(P)H oxidase and COX-1. Br J Pharmacol (2013) 0.77
Hope for the future: early recognition of increased cardiovascular risk in children and how to deal with it. Eur J Cardiovasc Prev Rehabil (2009) 0.77
Microvascular endothelial dysfunction in obesity and hypertension. Curr Pharm Des (2013) 0.77
Myocardial ultrasonic backscatter in hypertension: relation to aldosterone and endothelin. Hypertension (2003) 0.77
Birth weight and arterial hypertension. Curr Opin Cardiol (2015) 0.77
Vascular reactivity in patients with undifferentiated connective tissue diseases. Atherosclerosis (2008) 0.77
P2X7 receptor polymorphisms do not influence endothelial function and vascular tone in neo-diagnosed, treatment-naive essential hypertensive patients. J Hypertens (2013) 0.77